HIV Treatment
Fortæl dine venner om denne vare:
Bestilles fra fjernlager
Julegaver kan byttes frem til 31. januar
The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists.
150 pages
| Medie | Bøger Hardcover bog (Bog med hård ryg og stift omslag) |
| Udgivet | 8. september 2016 |
| ISBN13 | 9789535126669 |
| Forlag | Intechopen |
| Antal sider | 150 |
| Mål | 180 × 260 × 10 mm · 444 g |
| Sprog | Engelsk |
| Klipper/redaktør | Basaran, Ozcan |
| Klipper/redaktør | Biteker, Murat |